Freestone Grove Partners’s Elanco Animal Health ELAN Stock Holding History

Freestone Grove Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.4M	Buy	+2,170,681	New	+$50.2M	0.34%	75
2025 Q4	–	Sell	-3,841,422	Closed	-$77.4M	–	788
2025 Q3	$77.4M	Sell	3,841,422 -9,628	-0.3%	-$161K	0.58%	34
2025 Q2	$55M	Buy	3,851,050 +643,715	+20%	+$7.52M	0.42%	79
2025 Q1	$33.7M	Buy	3,207,335 +1,523,145	+90%	+$17.2M	0.35%	101
2024 Q4	$20.4M	Buy	+1,684,190	New	+$22M	0.25%	132

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Freestone Grove Partners's ELAN Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in Elanco Animal Health (ELAN) in Q2 2026: 2,170,681 shares worth $53.4M. The stake represents 0.34% of the portfolio and ranks #75 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in ELAN as recently as Q3 2025.

Freestone Grove Partners first reported a position in ELAN in Q4 2024 and has held it in 5 quarters since. The position peaked at $77.4M in Q3 2025. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Freestone Grove Partners held 2,170,681 shares of Elanco Animal Health worth $53.4M as of Q2 2026.
Elanco Animal Health was a new Freestone Grove Partners position in Q2 2026.
Elanco Animal Health made up 0.34% of Freestone Grove Partners's portfolio in Q2 2026, its #75 holding.
Freestone Grove Partners first reported a position in Elanco Animal Health in Q4 2024 and has held it in 5 quarters since.
Freestone Grove Partners's Elanco Animal Health position peaked at $77.4M in Q3 2025.
520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.